These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12884913)

  • 1. P21-activated kinases in human cancer.
    Vadlamudi RK; Kumar R
    Cancer Metastasis Rev; 2003 Dec; 22(4):385-93. PubMed ID: 12884913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging functions of p21-activated kinases in human cancer cells.
    Kumar R; Vadlamudi RK
    J Cell Physiol; 2002 Nov; 193(2):133-44. PubMed ID: 12384990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting group II PAKs in cancer and metastasis.
    Eswaran J; Soundararajan M; Knapp S
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):209-17. PubMed ID: 19160016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of the p21-activated kinases.
    Bokoch GM
    Annu Rev Biochem; 2003; 72():743-81. PubMed ID: 12676796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P21 activated kinases: structure, regulation, and functions.
    Rane CK; Minden A
    Small GTPases; 2014; 5():. PubMed ID: 24658305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21-activated kinases in cancer.
    Kumar R; Gururaj AE; Barnes CJ
    Nat Rev Cancer; 2006 Jun; 6(6):459-71. PubMed ID: 16723992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pak protein kinases and their role in cancer.
    Dummler B; Ohshiro K; Kumar R; Field J
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):51-63. PubMed ID: 19165420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho family GTPase signaling through type II p21-activated kinases.
    Chetty AK; Ha BH; Boggon TJ
    Cell Mol Life Sci; 2022 Nov; 79(12):598. PubMed ID: 36401658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21-activated kinases: three more join the Pak.
    Jaffer ZM; Chernoff J
    Int J Biochem Cell Biol; 2002 Jul; 34(7):713-7. PubMed ID: 11950587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P21 activated kinase signaling in cancer.
    Rane CK; Minden A
    Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp.
    Weisz Hubsman M; Volinsky N; Manser E; Yablonski D; Aronheim A
    Biochem J; 2007 Jun; 404(3):487-97. PubMed ID: 17355222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21-activated protein kinase: a crucial component of morphological signaling?
    Daniels RH; Bokoch GM
    Trends Biochem Sci; 1999 Sep; 24(9):350-5. PubMed ID: 10470034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Rac/Cdc42/PAK pathway in cytoskeletal rearrangements.
    Szczepanowska J
    Acta Biochim Pol; 2009; 56(2):225-34. PubMed ID: 19513348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAK thread from amoeba to mammals.
    Kumar A; Molli PR; Pakala SB; Bui Nguyen TM; Rayala SK; Kumar R
    J Cell Biochem; 2009 Jul; 107(4):579-85. PubMed ID: 19350548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
    Parvathy M; Sreeja S; Kumar R; Pillai MR
    BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAKs in the brain: Function and dysfunction.
    Civiero L; Greggio E
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):444-453. PubMed ID: 29129728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.
    Menges CW; Sementino E; Talarchek J; Xu J; Chernoff J; Peterson JR; Testa JR
    Mol Cancer Res; 2012 Sep; 10(9):1178-88. PubMed ID: 22798428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21-Activated Kinases in Thyroid Cancer.
    Bautista L; Knippler CM; Ringel MD
    Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32609833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer.
    Cheng Z; Liu F; Wang G; Li Y; Zhang H; Li F
    Cell Signal; 2014 Dec; 26(12):2667-73. PubMed ID: 25152372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAKs in human disease.
    Chan PM; Manser E
    Prog Mol Biol Transl Sci; 2012; 106():171-87. PubMed ID: 22340718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.